Board logo

標題: 牙齒產業……DENTSPLY international (美股 XRAY) [打印本頁]

作者: kaka    時間: 2015-12-4 22:39     標題: 牙齒產業……DENTSPLY international (美股 XRAY)

牙齒產業很專業……有相當優良的好公司
DENTSPLY international (美股 XRAY) 是很好的目標,提供同學參考……
作者: mikeon88    時間: 2015-12-5 08:28


作者: Yvens    時間: 2015-12-5 23:31

請教一下KAKA兄..這支....雖有極佳產業地位,
但目前離淑價又遠....配息僅約12%....
不知推薦理由為何?
還是說等等等...伺機進場?
作者: kaka    時間: 2015-12-5 23:51

建立自己的投資名單,等待機會
配息及庫藏股的說明,同學可參考mike桑的資料及盈再表
作者: bkuo    時間: 2017-11-25 19:42

找牙醫報到使用dentsply xive系統, 所以把瀏覽資料摘要( 約3秒鐘的內容 )上來給大家參考:


隨著科技發展,植體也不斷進化,即使是大廠牌也可能會大幅改變植體的設計,有些仍生產早期系統零件供老客戶更換使用,「從經驗上,我比較偏好主結構設計沒有歷經太大變革的產品,且具有長期臨床實證的植體品牌,像是Dentsply Sirona 旗下的登士派植體系列:德國品牌的Ankylos安德斯系統與Xive賽芙系統、瑞典品牌的Astra Tech Implant System亞仕特系統,都具有長期的臨床文獻報告,且在全球各地與台灣都是牙醫師主流使用的植體材料」。其實Dentsply Sirona 原本分屬兩間百年以上的世界級大公司,2016年兩間公司合併後,Dentsply Sirona成為全球最大的專業牙科產品與技術集團,在台灣也設有直屬的子公司與專業牙科團隊提供牙科產品的銷售服務與技術支援。 ( https://goo.gl/MZ6Pc1 )


(2013)全球前五大植牙體廠商依序是瑞典的Nobel Biocare、瑞士的Staumann、美國的Dentsply、美國的Biomet與美國的Zimmer,前兩名的市占率達四○%。 ( https://goo.gl/9nzz3F )

曾經收到嘉信理財設定的52WK low到價通知, 還不確定要不要入手, 幾天後它就不回頭了.
作者: kaka    時間: 2017-11-26 14:28

Zimmer 與 Biomet 已合併成為 Zimmer Biomet
https://en.m.wikipedia.org/wiki/Zimmer_Biomet

作者: Guanguan    時間: 2017-11-26 15:25

配息可能要留意一下...

作者: Jamescctungus    時間: 2017-12-16 15:45

Nobel Biocare 是不是私有化了? Google Finance 或MarketWatch都看不到2017的報價或財報. 謝謝
作者: kaka    時間: 2017-12-16 16:10

https://en.m.wikipedia.org/wiki/Nobel_Biocare

The new century


In 2002, the company changed its organizational structure by establishing a domicile in Switzerland with a newly founded group parent company. The primary listing of the shares was changed to the SIX SwissExchange (in 2008, the listing at the OMX Exchange in Stockholm was discontinued).

In 2014, Danaher bought Nobel Biocare[4] and as of 2015 is no longer listed on the SIX SwissExchange.
作者: Jamescctungus    時間: 2017-12-16 16:40

Kaka桑, 厲害厲害 !
作者: kaka    時間: 2017-12-16 16:56

Danaher Corporation ( 美股 DHR )
https://en.m.wikipedia.org/wiki/Danaher_Corporation

http://www.danaher.com/who-we-are


http://financials.morningstar.com/ratios/r.html?t=DHR


作者: kaka    時間: 2017-12-16 21:05

http://www.danaher.com/our-businesses/dental/nobel-biocare

http://www.danaher.com/our-businesses/business-directory

[ 本帖最後由 kaka 於 2017-12-16 21:09 編輯 ]
作者: kaka    時間: 2017-12-17 14:17

Straumann Holding AG  (瑞士  STMN , 美股 SAUHY,SAUHF )

https://en.m.wikipedia.org/wiki/Straumann

http://www.straumann.com.tw

http://financials.morningstar.com/ratios/r.html?t=SAUHY

http://financials.morningstar.com/ratios/r.html?t=SAUHF






作者: kaka    時間: 2017-12-17 14:40

以上應可回覆5樓同學的全球前4大植牙體廠商……
作者: kaka    時間: 2017-12-29 12:23

  1.     http://www.sirona.com/en/news-events/news-press/corporate-news-detail/33247/
  2. 29.02.2016
  3. Dentsply Sirona: Merger Creates The Dental Solutions CompanyTM

Dentsply Sirona Inc. (NASDAQ: XRAY) today announced that it has successfully completed the merger of equals between DENTSPLY International Inc. (“Dentsply”) and Sirona Dental Systems, Inc. (“Sirona”). The merger of DENTSPLY, the market leader in dental consumables and Sirona, the market leader in dental technology and equipment, creates the world’s largest and most diversified manufacturer of professional dental products and technologies. Dentsply Sirona will have leading positions and some of the most well-established brands across consumables, equipment, technology, and specialty products to address the needs of dental professionals, specialists and dental labs. Each day, approximately 600,000 dental professionals will use a Dentsply Sirona product.* With the largest R&D platform in the industry, Dentsply Sirona will develop and support innovative end-to-end clinical solutions that advance patient care.



[ 本帖最後由 kaka 於 2017-12-29 12:25 編輯 ]
作者: Curry    時間: 2018-2-6 16:34

植牙&假牙排名:
Straumann Group最大(23%) (瑞士  STMN , 美股 SAUHY,SAUHF )Danaher第二(19%) ( 美股 DHR )(前兩名已佔約四成,且前兩名相差不大)
Zimmer Biomet (NYSE: ZBH)第三(10%)Dentsply Sirona Inc. (NASDAQ: XRAY)第四(7%)(後面兩相差不大)

依據Straumann Group – 2016 Annual Report來源
https://www.straumann.com/content/dam/media-center/group/en/documents/annual-report/2016/Markets.pdf


另外文章說明:
Institut Straumann AG (Switzerland), Danaher Corporation (U.S.), and DENTSPLY Sirona (U.S.) Dominated the Global Dental Implants Market

https://www.marketsandmarkets.com/ResearchInsight/dental-implants-prosthetics-market.asp

Theglobal dental implants market is consolidated in nature. The market isdominated by Danaher Corporation (U.S.), DENTSPLY Sirona (U.S.), InstitutStraumann AG (Switzerland), Zimmer Biomet Holdings Inc. (U.S.), and 3M Company(U.S.). The dominance of the above companies can be attributed to their widegeographic footprints, strong product portfolios, and large established clientbases. The rest of the market is fragmented in nature with the presence of manylocal and regional players.
Institut Straumann AG (Switzerland) was the leading market playerin the dental implants market in 2015. The company manufactures and developsdental prosthetics, dental implants, instruments, and tissue regenerationproducts that are primarily used in tooth replacement and restoration. Thecompany has a strong presence in over 70 countries globally, and its productsand services are available through a wide network of distribution subsidiariesand partners. Institut Straumann AG primarily focuses on strengthening itsdental implants and prosthetics portfolio and aims to maintain customersatisfaction by providing technologically advanced products and services, andtimely responses and resolutions to customer needs. The company significantlyinvests in R&D to drive innovation and in sales & marketing activitiesto capture growth potential in underpenetrated markets. In order to increaseits customer base and maintain its position in the dental implants andprosthetics market, the company focuses on various growth strategies such asacquisitions, agreements, and new product launches.
Danaher Corporation (U.S.) held the second-largest share in thedental implants market in 2015. The company has a strong presence across NorthAmerica, Europe, Australia, and Asia, with manufacturing facilities located inNorth America, South America, Europe, and Asia for its dental care business.The company has a diversified revenue system, which helps it to sustain itsleading position in the market. To garner the leading position in dental implantsand prosthetics market, the company focuses on acquisition and new productlaunches. For instance, in December 2014, the company acquired Nobel BiocareHolding AG (Switzerland), a global dental implants and prosthetics solutionscompany. This enabled Danaher to combine Nobel Biocare’s expertise in implantand dental prosthetics with its capabilities in 3D imaging, scanners, anddigital restorative solutions, enabling optimization in clinical workflows.
DENTSPLY Sirona was the third-largest player in the dentalimplants market in 2015. The company is mainly engaged in manufacturing ofCAD/CAM, imaging systems, and dental specialty products for endodontics,orthodontics, and implants. DENTSPLY Sirona Inc. has a strong presence in theU.S. and operates in around 120 countries across Europe; North, Central, andSouth America; South Africa; and the Pacific Rim. The company has adoptedmergers and acquisitions as its major growth strategy. For instance, inFebruary 2016, DENTSPLY International Inc. (U.S.) merged with Sirona DentalSystems, Inc. (U.S.). The merger helped the company in offering a powerful setof complementary products in the dental market.
Industry players adopted various strategies to achieve growth inthe dental implants and prosthetics market; however, the major strategy usedbetween 2013 and 2016 to achieve growth globally was new product launches. InJune 2016, Nobel Biocare, a subsidiary of Danaher Corporation (U.S.) launchedthe Locator R-Tx, a removable denture attachment system. In addition, in March2016, Zimmer Biomet Holdings, Inc. (U.S.) launched the new 3.1 mmD EzteticImplant. Partnerships, agreements, and collaborations were the other strategiesadopted by the top players in the dental implants and prosthetics market. Forinstance, in June 2016, DENTSPLY Sirona Inc. (U.S.) acquired MIS ImplantsTechnologies Ltd. (Israel), a dental implant systems manufacturer.


[ 本帖最後由 Curry 於 2018-2-6 16:43 編輯 ]
作者: bkuo    時間: 2018-2-7 05:05

謝謝kaka桑以及Curry桑的資訊, 種牙有感, 相信是好果樹一顆, 希望這回能夠等到一個好價格入手.




[ 本帖最後由 bkuo 於 2018-2-7 05:15 編輯 ]
作者: Curry    時間: 2018-2-7 10:11

昨天看牙齒有再請教牙醫同鞋,在牙齒產業除了植牙&假牙是否還有其他利基產品(講白了就是比較賺錢的),她有提到隱適美(隱形矯正牙套)ALGN,但ALGN的營收才XRAY的一半,且隱適美是進幾年才流行的產品,另外隨ALGN的利基產品隱適美專利到期牙材巨怪(Straumann Group (瑞士  STMN , 美股 SAUHY,SAUHF )、Danaher ( 美股 DHR )、Zimmer Biomet (NYSE: ZBH)、Dentsply Sirona Inc.)陸續進入隱適美產業,ALGN可能會被併或是GG。


總結:
牙材產業最主要就是看植牙&假牙廠商,牙醫同鞋昨天提到這兩個產品是從她在醫學院就一直在學,只是技術不斷演進,所以看得出這兩個利基產品在牙材產業是不變的,而Straumann Group、Danaher、Zimmer Biomet、Dentsply Sirona Inc.,這四家我比較推薦買Danaher,因Straumann Group及Danaher兩家其實在伯仲之間,但相較之下Danaher較穩,而Zimmer Biomet及Dentsply Sirona Inc.兩家加起來還不及Danaher,若Danaher能併Zimmer Biomet及Dentsply Sirona Inc.兩者其中一個那就更棒了!






作者: Curry    時間: 2018-2-7 10:13

先前對ALGN的分析連結:ALGN
作者: lounge19    時間: 2018-2-8 10:12

請教Curry, 你是用最新版的盈再表嗎?為什麼我的ZBH盈再表跑出來的跟你的差很大?

作者: Curry    時間: 2018-2-8 10:38

lounge19
麻煩您先看先前討論:這波美股修正,最想買的股票會是哪一隻
這樣有看到不同了?
若真的還是看不出來再Q一下!

作者: jaynd    時間: 2018-8-7 22:21

Xray 大跌revenue and eps beat
revenue up 5% compared to prior year
repurchased 5.4 million shares
不懂為什麼跌
希望之前有在關注的同學可以找到好的入點
作者: 須彌芥子    時間: 2018-8-7 23:11


作者: Raimu    時間: 2018-8-7 23:28

奇怪
為什麼XRAY的股數膨脹這麼快
整個ROE都爛掉了




歡迎光臨 巴菲特班 洪瑞泰 (Michael On) (http://mikeon88.freebbs.tw/) Powered by Discuz! 5.0.0